Every drug hunting project needs its own IP strategy but the current purely market-driven approaches to drug discovery and development alone are insufficient to drive equitable access to new therapies either in preparation for, or in response to, pandemics.
Following the experiences gained from the COVID Moonshot program and the ASAP AViDD drug discovery consortium, the authors of this paper share a model that prioritises globally fair and affordable pricing by creating ‘maximally permissive licenses’ based on ‘minimally defensive patents’.
Read the full article to discover the practical and bioethical background to their proposals and an example of collective management of intellectual property and licensing agreement that is being used in the AI-driven Structure-enabled Antiviral Platform (ASAP) Center’s Pandemic Preparedness work.
Griffen EJ, Boulet P, ASAP Discovery Center and COVID Moonshot. Enabling equitable and affordable access to novel therapeutics for pandemic preparedness and response via creative intellectual property agreements [version 1; peer review: 3 approved]. Wellcome Open Res 2024, 9:374 (https://doi.org/10.12688/wellcomeopenres.22645.1).
